NCT00523549View on ClinicalTrials.gov

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
HypertensionDiastolic Dysfunction
Interventions
DRUG

valsartan

160 mg or 320 mg tablets once a day

DRUG

amlodipine

5 mg or 10 mg tablets once a day

Trial Locations (1)

Unknown

Novartis Investigative Sites, USA

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY